AmerisourceBergen Corp (ABC) - Financial and Strategic SWOT Analysis Review

AmerisourceBergen Corp (ABC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company that offers pharmaceutical products, business solutions, and value-driving services that improve access to care. The company distributes a broad offering of brand-name, specialty brand-name, over-the-counter(OTC) healthcare products, generic pharmaceuticals, equipment, home healthcare supplies, outsourced compounded sterile preparations, and related services. It serves numerous healthcare providers in the US and selected global markets, comprising independent and chain retail pharmacies, acute care hospitals and health systems, medical clinics, mail-order pharmacies, medical and dialysis clinics, physician practices, long-term care and alternate site pharmacies, veterinarians, and other customers. AmerisourceBergen is headquartered in Conshohocken, Pennsylvania, the US.

AmerisourceBergen Corp Key Recent Developments

Dec 29, 2022: Justice department files nationwide lawsuit against AmerisourceBergen and subsidiaries for controlled substances act violations
Nov 03, 2022: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
Sep 13, 2022: AmerisourceBergen agrees to acquire PharmaLex for $1.29bn
Sep 06, 2022: HHS Awards $20 million contract to AmerisourceBergen to expand, quicken distribution of vaccines and treatments for monkeypox

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company

AmerisourceBergen Corp - Key Facts
AmerisourceBergen Corp - Key Employees
AmerisourceBergen Corp - Key Employee Biographies
AmerisourceBergen Corp - Major Products and Services
AmerisourceBergen Corp - History
AmerisourceBergen Corp - Company Statement
AmerisourceBergen Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview
AmerisourceBergen Corp - Business Description
Business Segment: International Healthcare Solutions
Overview
Performance
Business Segment: The US Healthcare Solutions
Overview
Performance
AmerisourceBergen Corp - Corporate Strategy
AmerisourceBergen Corp - SWOT Analysis
SWOT Analysis - Overview
AmerisourceBergen Corp - Strengths
AmerisourceBergen Corp - Weaknesses
AmerisourceBergen Corp - Opportunities
AmerisourceBergen Corp - Threats
AmerisourceBergen Corp - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
AmerisourceBergen Corp, Recent Deals Summary

Section 5 - Company’s Recent Developments

Dec 29, 2022: Justice department files nationwide lawsuit against AmerisourceBergen and subsidiaries for controlled substances act violations
Nov 03, 2022: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
Sep 13, 2022: AmerisourceBergen agrees to acquire PharmaLex for $1.29bn
Sep 06, 2022: HHS Awards $20 million contract to AmerisourceBergen to expand, quicken distribution of vaccines and treatments for monkeypox
Aug 03, 2022: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
Jul 27, 2022: AmerisourceBergen to launch digital therapeutics platform to facilitate access to innovative products
Jun 14, 2022: Fresenius Kabi expands RFID compatibility to improve hospital inventory management
Jun 01, 2022: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
May 24, 2022: AmerisourceBergen unveils Clinical Trial Navigator to boost community-based research
May 04, 2022: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results

Section 6 - Appendix

Methodology
Ratio Definitions
About the Publisher
Contact the Publisher
Disclaimer

List of Tables

AmerisourceBergen Corp, Key Facts
AmerisourceBergen Corp, Key Employees
AmerisourceBergen Corp, Key Employee Biographies
AmerisourceBergen Corp, Major Products and Services
AmerisourceBergen Corp, History
AmerisourceBergen Corp, Subsidiaries
AmerisourceBergen Corp, Key Competitors
AmerisourceBergen Corp, Ratios based on current share price
AmerisourceBergen Corp, Annual Ratios
AmerisourceBergen Corp, Interim Ratios
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
AmerisourceBergen Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

AmerisourceBergen Corp, Performance Chart (2017 - 2021)
AmerisourceBergen Corp, Ratio Charts
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

United Parcel Service Inc
MediPal Holdings Corp
McKesson Corp
Henry Schein Inc
Cardinal Health Inc

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€122EUR$125USD£102GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€244EUR$250USD£204GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€366EUR$375USD£306GBP